| 7:30 am |
Registration Open | Exhibit Hall Open | Breakfast and Networking |
| 7:30 am-8:30 am |
BIO Partnering Meetings |
| 8:30 am-8:40 am |
Welcome and Opening Remarks |
8:45 am-9:45 am
(concurrent panel sessions) |
SESSION A
Track 1
Changing the Landscape for Cell and Gene Therapy
Maryland’s Center of Excellence
Moderator:
Margot Connor, Chief Executive Officer, RoosterBio
Panelists:
Emily English, Ph.D., Chief Executive Officer, Gemstone Therapeutics
Kimberly Noonan, Ph.D., Founder, Executive Vice President and Chief Scientific Officer, WindMIL Therapeutics
William Rust, Ph.D., Chief Executive Officer and Co-Founder, Seraxis
Track 2
The Friends and Family Plan
Experts discuss different levels of early stage fundraising
Moderator:
Jeff Galvin, Chief Executive Officer and Founder, American Gene Technologies
Panelists:
Judy Costello, Managing Director, Economic Development, BioHealth Innovation
Henry Ahn, SBIR/STTR Program Director, National Science Foundation – Invited
Joseph Naft, Director, Maryland Industrial Partnerships (MIPS) Program
Paul Silber, Founding Principal, Blu Venture Investors
|
10:00 am – 11:00 am
Sponsored by Maxcyte |
Keynote Address
Hopes for a Cure – Gene Therapy for Sickle Cell Anemia
Keynote Speaker:
John F. Tisdale, M.D., Senior Investigator, National Heart, Lung and Blood Institute
|
11:15 am-12:15 pm
(concurrent panel sessions) |
SESSION B
Track 1
Life Saving Therapies, Heart Stopping Prices
Navigating Reimbursement
Panelists:
Brian Abraham, Director,Market Access, Life Sciences, BDO
Track 2
Employment Opportunities Fulfilled
The demand for life sciences job skills is growing rapidly in this region. Our roundtables will discuss opportunities and challenges while determining actions which can be taken to ensure workforce readiness and availability for the near-, mid- and long-term.
|
12:15 pm-1:30 pm
Sponsored by Towson University |
Networking Lunch in the Exhibit Hall
BIO Partnering Meetings
|
1:30 pm-2:30 pm
(concurrent panel sessions) |
SESSION C
Track 1
Regulatory
Panelists:
David Feigal, M.D., MPH, Partner, NDA Partners
Track 2
Strategic Market Planning for Capital and Commercialization
Experts discuss key considerations and timing for market assessments to drive strategic partnering options and optimized commercial launch success
Moderator:
Steven Walker, MBA, MHA, Chief Business Officer and Commercial Strategist, Biologics Consulting
Panelists:
Luis Gutierrez, Past President, Commercialization Services, Covance
Ram Palanki, Pharm.D., Senior Vice President of Commercial Strategy and Operations, REGENXBIO
Tyrell Rivers, Ph.D., Executive Director of Corporate Development, AstraZeneca
|
2:45 pm-3:45 pm
(concurrent panel sessions) |
SESSION D
Track 1
New Frontiers of Biomanufacturing
Track 2
Past Seed Stage to the Last Mile
Experts discuss later stage fundraising opportunities
Moderator:
Linda Segal, Principal, The McCormick Group
Panelists:
Subhendu Basu, Ph.D., Senior Director and Department Head, Scientific Affairs, CSO & Executive Offices, Emergent BioSolutions
Diana Bernstein, Ph.D., Senior Associate, Merck Ventures
Pete Buzy, Chief Executive Officer, Paragon Biosciences
Jacob Vogelstein, General Partner, Camden Partners
|
| 4:00 pm-5:00 pm |
Keynote Address
|
| 5:00 pm-6:00 pm |
Cocktail Reception
|
